In 2010, we described a regulatory mechanism whereby a selective ER-downregulator is able to up-regulate P-cadherin expression in MCF-7/AZ breast cancer cells through chromatin remodelling at CDH3 promoter level [18]. The gene discussed is CDH3; the disease is breast carcinoma.